Aster DM Healthcare Limited

BSE:540975 Stock Report

Market Cap: ₹266.3b

Aster DM Healthcare Valuation

Is 540975 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 540975 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
₹419.34
Fair Value
27.6% overvalued intrinsic discount
9
Number of Analysts

Below Fair Value: 540975 (₹535.15) is trading above our estimate of fair value (₹419.34)

Significantly Below Fair Value: 540975 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 540975?

Key metric: As 540975 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 540975. This is calculated by dividing 540975's market cap by their current earnings.
What is 540975's PE Ratio?
PE Ratio107.6x
Earnings₹2.47b
Market Cap₹266.31b

Price to Earnings Ratio vs Peers

How does 540975's PE Ratio compare to its peers?

The above table shows the PE ratio for 540975 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average63.1x
KIMS Krishna Institute of Medical Sciences
74x28.8%₹257.6b
NH Narayana Hrudayalaya
47.2x14.7%₹370.0b
MEDANTA Global Health
64.1x20.7%₹325.2b
FORTIS Fortis Healthcare
67x21.9%₹515.4b
540975 Aster DM Healthcare
107.6x38.5%₹266.3b

Price-To-Earnings vs Peers: 540975 is expensive based on its Price-To-Earnings Ratio (107.6x) compared to the peer average (63.1x).

Price to Earnings Ratio vs Industry

How does 540975's PE Ratio compare vs other companies in the IN Healthcare Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
523696 Fortis Malar Hospitals
2.5xn/aUS$16.05m
530897 N G Industries
4.4xn/aUS$6.28m
542918 Gian Life Care
4.2xn/aUS$1.94m
No more companies available in this PE range
540975 107.6xIndustry Avg. 38.3xNo. of Companies7PE020406080100+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 540975 is expensive based on its Price-To-Earnings Ratio (107.6x) compared to the Indian Healthcare industry average (38.6x).

Price to Earnings Ratio vs Fair Ratio

What is 540975's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

540975 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio107.6x
Fair PE Ratio73x

Price-To-Earnings vs Fair Ratio: 540975 is expensive based on its Price-To-Earnings Ratio (107.6x) compared to the estimated Fair Price-To-Earnings Ratio (73x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 540975 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹535.15
₹576.67
+7.8%
13.8%₹729.00₹410.00n/a9
May ’26₹505.00
₹576.67
+14.2%
13.8%₹729.00₹410.00n/a9
Apr ’26₹479.95
₹576.78
+20.2%
13.8%₹730.00₹410.00n/a9
Mar ’26₹402.60
₹568.22
+41.1%
15.4%₹730.00₹410.00n/a9
Feb ’26₹476.35
₹558.89
+17.3%
16.2%₹735.00₹410.00n/a9
Jan ’26₹520.75
₹565.00
+8.5%
11.1%₹665.00₹435.00n/a8
Dec ’25₹499.95
₹507.50
+1.5%
8.5%₹575.00₹435.00n/a8
Nov ’25₹444.55
₹491.88
+10.6%
6.0%₹535.00₹435.00n/a8
Oct ’25₹417.85
₹424.00
+1.5%
5.5%₹457.00₹385.00n/a8
Sep ’25₹406.60
₹419.29
+3.1%
5.0%₹450.00₹385.00n/a7
Aug ’25₹368.05
₹410.83
+11.6%
5.8%₹450.00₹370.00n/a6
Jul ’25₹350.10
₹410.83
+17.3%
5.8%₹460.00₹385.00n/a6
Jun ’25₹362.80
₹410.83
+13.2%
5.8%₹460.00₹385.00n/a6
May ’25₹348.60
₹489.00
+40.3%
2.8%₹515.00₹480.00₹505.005
Apr ’25₹407.85
₹486.00
+19.2%
1.6%₹500.00₹480.00₹479.955
Mar ’25₹461.60
₹486.00
+5.3%
1.6%₹500.00₹480.00₹402.605
Feb ’25₹431.95
₹420.00
-2.8%
1.7%₹430.00₹410.00₹476.355
Jan ’25₹404.85
₹420.00
+3.7%
1.7%₹430.00₹410.00₹520.755
Dec ’24₹401.05
₹396.67
-1.1%
13.3%₹430.00₹280.00₹499.956
Nov ’24₹330.20
₹327.38
-0.9%
11.1%₹380.00₹262.00₹444.558
Oct ’24₹328.00
₹320.44
-2.3%
12.3%₹380.00₹262.00₹417.859
Sep ’24₹329.30
₹319.89
-2.9%
12.2%₹380.00₹262.00₹406.609
Aug ’24₹319.35
₹305.78
-4.2%
9.1%₹350.00₹262.00₹368.059
Jul ’24₹279.65
₹298.44
+6.7%
9.8%₹350.00₹262.00₹350.109
Jun ’24₹270.55
₹298.44
+10.3%
9.8%₹350.00₹262.00₹362.809
May ’24₹246.55
₹270.67
+9.8%
7.2%₹310.00₹235.00₹348.609
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
₹576.83
Fair Value
7.2% undervalued intrinsic discount
9
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/07 05:08
End of Day Share Price 2025/05/07 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Aster DM Healthcare Limited is covered by 21 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Harith AhamedAvendus Spark
Vijayaraghavan SwaminathanAvendus Spark
null nullAxis Capital Limited